Explore tweets tagged as #CPPPLU
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
11 days
The CPP Section’s June Pharmacotherapy Literature Update features 10 summaries of recent publications on topics such as cardiogenic shock, early NE in septic shock, & inhaled sedation in ARDS. CPP members can access this through Connect: #PharmICU #CPPPLU
Tweet media one
0
3
17
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
17 days
#CPPPLU Highlights: The EXPECTS Trial from @NEJM evaluated the safety and efficacy of alteplase between 4.5 to 24 hours after posterior circulation ischemic stroke. Treatment resulted in increased frequency of functional independence at 90 days. #PharmICU
Tweet media one
1
2
6
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
1 month
The May #CPPPLU features 9 summaries of recent publications including albumin in septic shock & renal failure, aminoglycosides in urosepsis, & reversal of rocuronium in CT surgery patients with COVID-19. 💉 Check it out via @SCCM Connect: #PharmICU #CPPPLU
Tweet media one
1
4
16
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
1 day
#CPPPLU Highlight: A meta-analysis published in @Crit_Care found an association between early initiation of norepinephrine and reduced mortality in patients with septic shock. #PharmICU
Tweet media one
1
0
1
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
1 month
#CPPPLU Highlights: A recent feasibility study in @critcaremed found that dexmedetomidine administration in septic shock resulted in a ↓ in vasopressor responsiveness and an ↑ in early mortality #PharmICU #CPPPLU.
Tweet media one
2
4
14
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
18 days
#CPPPLU Highlights: A recent RCT in @JCVAonline examining hydroxocobalamin administration at the end of cardiopulmonary bypass showed significantly higher MAP compared to placebo as well as reduction in development of vasoplegia. #PharmICU #CPPPLU
Tweet media one
1
3
7
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
1 month
#CPPPLU Highlights: Nelonemdaz, a novel NMDA receptor subtype 2B-selective antagonist and potent free-radical scavenger, may improve outcomes in OHCA, seen in the phase II AWAKE trial in @CritCareMed. #PharmICU
Tweet media one
1
1
1
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
22 days
CPPPLU Highlights: A recent multicenter study in @of_AIC found that the addition of empiric aminoglycosides for urosepsis did not improve mortality, but also did not cause worsening nephrotoxicity. #PharmICU #CPPPLU
Tweet media one
1
3
6
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
5 days
#CPPPLU Highlights: This recent publication from @JACCJournals provides guidance on the evaluation and management of cardiogenic shock. Early diagnosis and management of cardiogenic shock is crucial. #PharmICU
Tweet media one
1
1
8
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
23 days
CPPPLU Highlights: New in @accpchest co-authored by CPP members Asad Patanwala, @AflanneryPharmD, and Brian Erstad: Early albumin (esp. 25%) in septic shock w/ renal impairment linked to ↑ RRT or death. Surprising signal of harm! #PharmICU #CPPPLU
Tweet media one
1
3
6
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
1 month
#CPPPLU Highlights: A study in @JCVAonline found that reversal of NMBA with sugammadex in COVID-19 patients undergoing CT surgery had ⬇️ pulmonary complications including pneumonia and respiratory failure. 💉 #PharmICU #CPPPLU
Tweet media one
1
2
3
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
16 days
#CPPPLU Highlights: This recent trial from @of_AIC explored the use of high-dose IV vitamin C in moderate to severe acute pancreatitis. They found a potential benefit on C-reactive protein levels and fluid retention in moderate illness. #PharmICU
Tweet media one
1
2
1
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
25 days
#CPPPLU Highlights: Rapid PCR testing in ICUs may improve antibiotic stewardship, but does not demonstrate non-inferiority to standard-of-care for clinical outcomes according to a recent study in @yourICM .#PharmICU #CPPPLU
Tweet media one
1
0
1
@JCVAonline
Journal of Cardiothoracic and Vascular Anesthesia
1 year
#CPPPLU Highlights. A recent study in @JCVAonline found that hydroxocobalamin was associated with a greater reduction in vasopressor requirements and ↑ in MAP compared to methylene blue for vasoplegic shock post-CPB. #PharmICU .
Tweet media one
0
2
7
@Tribidibidy
Melanie Smith Condeni
2 years
Can’t wait to hear @pwierusz thoughts on ang II use! Thanks to @SCCM_CPP and the #CPPPLU for highlighting these studies!.
@SCCM_CPP
SCCM Clinical Pharmacy and Pharmacology Section
2 years
Welcome! Thrilled to kick off our AMA on angiotensin II w/ @pwierusz & amazing co-authors. Drop your burning questions using #AMAAngiotensinII . Tap into the minds behind the research and let's get the conversation started on angiotensin II in vasodilatory shock! #PharmICU.
0
0
5